Your browser doesn't support javascript.
loading
First-in-Human Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of an Oral Formulation of DS-1040, an Inhibitor of the Activated Form of Thrombin-Activatable Fibrinolysis Inhibitor, in Healthy Subjects.
Zhou, Jin; Limsakun, Tharin; Yin, Ophelia; Warren, Vance; Zamora, Cynthia; Atiee, George; Kochan, Jarema; Pav, Joseph; Kobayashi, Fumiaki; Vashi, Vijay; Dishy, Victor.
Affiliation
  • Zhou J; Daiichi Sankyo, Inc, Basking Ridge, NJ, USA.
  • Limsakun T; Daiichi Sankyo, Inc, Basking Ridge, NJ, USA.
  • Yin O; Daiichi Sankyo, Inc, Basking Ridge, NJ, USA.
  • Warren V; Daiichi Sankyo, Inc, Basking Ridge, NJ, USA.
  • Zamora C; Worldwide Clinical Trials, San Antonio, TX, USA.
  • Atiee G; Worldwide Clinical Trials, San Antonio, TX, USA.
  • Kochan J; Daiichi Sankyo, Inc, Basking Ridge, NJ, USA.
  • Pav J; Daiichi Sankyo, Inc, Basking Ridge, NJ, USA.
  • Kobayashi F; Daiichi Sankyo, Inc, Basking Ridge, NJ, USA.
  • Vashi V; Daiichi Sankyo, Inc, Basking Ridge, NJ, USA.
  • Dishy V; Daiichi Sankyo, Inc, Basking Ridge, NJ, USA.
J Clin Pharmacol ; 59(12): 1669-1677, 2019 12.
Article in En | MEDLINE | ID: mdl-31243790

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carboxypeptidase B2 Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: J Clin Pharmacol Year: 2019 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carboxypeptidase B2 Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: J Clin Pharmacol Year: 2019 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido